Support
Support
Search

Cardiac Diagnostic Solutions for Health Plans1

A doctor and a patient having a conversation

Press Release

NAMCP Independent Third-Party Review Validates Value Proposition

Zio XT value proposition lives up to its claims and demonstrates high value around clinical utility and payer economics.
Read More

Cardiac Arrhythmia Diagnostic Solutions1

The Hidden Costs of Undetected Arrhythmias

A closer look at the impact on PMPM and healthcare resource utilizations.
Read More

Cardiac Arrhythmia Diagnostic Solutions1

The Strategic Impact on Health Plan Outcomes

The selection of a cardiac monitoring service to detect arrhythmias is a cornerstone to managing members with potential cardiovascular disease.
Read More

Patient journey

Why The Zio Long-term Continuous Monitoring (LTCM) Service is Essential

Streamlining the patient journey to address the Impact of undetected arrhythmias.
Read More

CAMELOT: NEW REAL-WORLD EVIDENCE

A new study, CAMELOT, continues the long history of evidence that Zio long-term continuous monitoring (LTCM) service provides value and performance with the highest diagnostic yield and lowest likelihood of retest among continuous cardiac monitoring services.2-5
Learn More
Woman wearing a Zio monitor

Transforming the way Cardiac Arrhythmias are Detected

As a market leader in cardiology diagnostics and arrhythmia detection, iRhythm has served more than ~8 million patients and analyzed 1.5 billion hours of heartbeat data through our Zio service.6,7

 

We’re on a mission to address the future of healthcare, partnering with risk-based organizations to detect and prevent cardiovascular disease - all while helping you save money and save lives.

CPT Codes8,9

Zio monitor

Zio LTCM10

93243

 

External electrographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; scanning analysis with report

 

93247

 

External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report.

Zio AT monitor transmitting

Zio AT11-13

93229

 

External mobile cardiovascular telemetry with electrocardiographic recording for up to 30 days.

 

Full CPT code description available at: www.cms.gov

Who We Serve

Value-based primary care

Accountable Care Organizations (ACOs)

Clinically Integrated Networks (CINs)

Health assessment organizations

Healthcare enablers

Payers/Payviders

Improve Key Performance Measures

Healthcare Effectiveness Data and Information Set (HEDIS) Measures + Cardiovascular Health

By integrating proactive surveillance for heart arrhythmias into routine care, you have the opportunity to drive better patient outcomes and impact key HEDIS measures related to cardiovascular health.

Find untapped value-based care opportunities. Contact us today.

  1. Preliminary findings in the Zio report are intended for use by clinicians as an aid in arrhythmia diagnosis and management.

  2. Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. Accessed January 2, 2024. 
    https://doi.org/10.1016/j.ahj.2023.12.002

  3. In testing for specified arrhythmias defined by Hierarchical Condition Categories (HCC) 96.
  4. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  5. Zio LTCM service refers to Zio XT and Zio monitor service.
  6. Data on file. iRhythm Technologies. 2023.
  7. Form 10-K 2023. iRhythm Technologies, 2023. Retrieved from https://s201.q4cdn.com/653785554/files/doc_financials/2022/ar/Annual-Report.pdf
  8. CPT Copyright 2012 American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the American Medical Association.
  9. CPT Disclaimer: Applicable FARS/DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
  10. Indications for Use: the Zio monitor is a prescription-only, single-use ambulatory ECG monitor that continuously records data for up to 14 days. It is indicated for use on patients 18 years and older, who may be asymptomatic or who may suffer from transient symptoms such as palpitations, shortness of breath, dizziness, light-headedness, pre-syncope, syncope, fatigue, or anxiety.
  11. Do not use Zio AT for patients with symptomatic episodes where variations in cardiac performance could result in immediate danger to the patient or when real-time or in-patient monitoring should be prescribed.  Refer to the Zio AT labeling Instructions for Use for full contraindications.
  12. This device is not intended for use in critical care patients because the reporting timeliness is not consistent with life-threatening arrhythmias such as ventricular fibrillation.
  13. The Zio AT device is a prescription only, single-use, continuously recording ECG monitor that can be worn up to 14 days.
Contact Us

WEB0014.01